Nuvelo Restarts Alfimeprase Trial For Central Venous Catheter Occlusion
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is enrolling patients in the SONOMA-3 trial after an earlier trial, SONOMA-2, failed.
You may also be interested in...
Nuvelo Begins Phase II Trial Of Thrombolytic For Ischemic Stroke
After poor Phase III results for catheter occlusion and loss of Bayer partnership, company cites optimism about efficacy in stroke.
Nuvelo Begins Phase II Trial Of Thrombolytic For Ischemic Stroke
After poor Phase III results for catheter occlusion and loss of Bayer partnership, company cites optimism about efficacy in stroke.
Nuvelo Discontinues Factor VIIa Inhibitor To Focus On Alfimeprase
As part of the realignment, Nuvelo will cut its work force by 30 percent and reduce annual expenses by $15 million.